EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Immunomodulatory and anti‐inflammatory properties of immunoglobulin G antibodies

Marjan Hematianlarki, Falk Nimmerjahn iD

Immunological Reviews · 2024

DOI: 10.1111/imr.13404 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, 2024. Verfasst von Marjan Hematianlarki und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Germany. Hauptthemen laut MEDLINE: Immunoglobulin G, Immunoglobulins, Intravenous. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibodies provide an essential layer of protection from infection and reinfection with microbial pathogens. An impaired ability to produce antibodies results in immunodeficiency and necessitates the constant substitution with pooled serum antibodies from healthy donors. Among the five antibody isotypes in humans and mice, immunoglobulin G (IgG) antibodies are the most potent anti‐microbial antibody isotype due to their long half‐life, their ability to penetrate almost all tissues and due to their ability to trigger a wide variety of effector functions. Of note, individuals suffering from IgG deficiency frequently produce self‐reactive antibodies, suggesting that a normal serum IgG level also may contribute to maintaining self‐tolerance. Indeed, the substitution of immunodeficient patients with pooled serum IgG fractions from healthy donors, also referred to as intravenous immunoglobulin G (IVIg) therapy, not only protects the patient from infection but also diminishes autoantibody induced pathology, providing more direct evidence that IgG antibodies play an active role in maintaining tolerance during the steady state and during resolution of inflammation. The aim of this review is to discuss different conceptual models that may explain how serum IgG or IVIg can contribute to maintaining a balanced immune response. We will focus on pathways depending on the IgG fragment crystallizable (Fc) as pre‐clinical data in various mouse model systems as well as human clinical data have demonstrated that the IgG Fc‐domain recapitulates the ability of intact IVIg with respect to its ability to trigger resolution of inflammation. We will further discuss how the findings already have or are in the process of being translated to novel therapeutic approaches to substitute IVIg in treating autoimmune inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulin GImmunoglobulins, IntravenousHumansAnimalsMiceInflammationAnti-Inflammatory AgentsImmunomodulationImmunoglobulin Fc FragmentsImmune Tolerance

Stichwörter der Autor:innen

autoimmunityfc‐receptorsimmunoglobulin Gintravenous immunoglobulinresolution of inflammation

Substanzen

Immunoglobulin GImmunoglobulins, IntravenousAnti-Inflammatory AgentsImmunoglobulin Fc Fragments

Autor:innen und Institutionen

  • Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Germany.

ORCID-Profile: Falk Nimmerjahn

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Hematianlarki, M., & Nimmerjahn, F. (2024). Immunomodulatory and anti‐inflammatory properties of immunoglobulin G antibodies. Immunological Reviews. https://doi.org/10.1111/imr.13404

Vancouver

Hematianlarki M, Nimmerjahn F. Immunomodulatory and anti‐inflammatory properties of immunoglobulin G antibodies. Immunological Reviews. 2024. doi:10.1111/imr.13404

BibTeX
@article{Hematianlarki2024,
  author = {Hematianlarki, Marjan and Nimmerjahn, Falk},
  title = {Immunomodulatory and anti‐inflammatory properties of immunoglobulin G antibodies},
  journal = {Immunological Reviews},
  year = {2024},
  doi = {10.1111/imr.13404}
}
Kostenlos starten →